Last updated: April 24, 2026

Application No. 18/278,797

Untitled Application

Unknown

Filed

1600

Examiner

BENAVIDES, JENNIFER ANN

Art Unit

1675

Tech Center

ImmunityBio, Inc.

Assignee

Immunitybio Inc.

OA Round

1 (Non-Final)

This examiner grants 49% of cases after interview

— +46.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 107 resolved cases, 2023–2026

Examiner Intelligence

BENAVIDES, JENNIFER ANN View full profile →

Grants 49% of resolved cases

Career Allow Rate

52 granted / 107 resolved

-11.4% vs TC avg

Strong +47% interview lift

Without

With

+46.9%

Interview Lift

resolved cases with interview

Typical timeline

2y 6m

Avg Prosecution

45 currently pending

Career history

152

Total Applications

across all art units

Statute-Specific Performance

§101

3.3%

-36.7% vs TC avg

§103

30.5%

-9.5% vs TC avg

§102

13.4%

-26.6% vs TC avg

§112

31.0%

-9.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 107 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/759,800

Patent 12596122

NOVEL LILRB2 ANTIBODIES AND USES THEREOF

2y 5m to grant Granted Apr 07, 2026

17/775,167

Patent 12595310

COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR 1 TARGETING

2y 5m to grant Granted Apr 07, 2026

18/423,089

Patent 12582713

METHODS OF TREATING TUMORS

2y 5m to grant Granted Mar 24, 2026

17/642,674

Patent 12570725

ZIKA ANTIBODIES AND THEIR USE

2y 5m to grant Granted Mar 10, 2026

17/827,630

Patent 12570767

Sequences of anti-ecto-5'-nucleotidase antibodies

2y 5m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

49%

Grant Probability

96%

With Interview (+46.9%)

2y 6m

Median Time to Grant

Low

PTA Risk

Based on 107 resolved cases by this examiner. Grant probability derived from career allow rate.